Biofil Chemicals and Pharmaceuticals Limited (BOM:524396)

India · Delayed Price · Currency is INR

30.40

+0.15 (0.50%)

At close: Nov 6, 2026

Market Cap	494.72M -23.2%
Revenue (ttm)	346.26M +1.3%
Net Income	4.84M -82.7%
EPS	0.30 -82.6%
Shares Out	16.27M
PE Ratio	101.20
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	769
Open	30.11
Previous Close	30.25
Day's Range	30.11 - 31.59
52-Week Range	25.60 - 46.82
Beta	0.58
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2026

About BOM:524396

Biofil Chemicals and Pharmaceuticals Limited engages in the manufacturing and trading of pharmaceutical products in India. It operates through Pharma and Chemical segments. The company offers basic drugs and chemicals, including sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrus fumerate, micro crystalline cellulose, and dicyclomine hydrochloride. It also provides ferrous sulphate in crystal, exsiccated, and granular form; microcrystalline cellulose powder; cellulos... [Read more]

Industry Pharmaceutical Preparations

Founded 1985

Employees 24

Stock Exchange Bombay Stock Exchange

Ticker Symbol 524396

Full Company Profile

Financial Performance

In fiscal year 2026, BOM:524396's revenue was 283.95 million, a decrease of -15.45% compared to the previous year's 335.82 million. Earnings were 27.86 million, an increase of 399.55%.

Financial Statements